BTI
PCRX icon

Blue Trust Inc’s Pacira BioSciences PCRX Stock Holding History

Blue Trust Inc’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-59
Closed -$1.69K – 2833
2024
Q3 		$1.69K Buy
59
+26
+79% +$445 ﹤0.01% 2612
2024
Q2 		$964 Buy
+33
New +$939 ﹤0.01% 2549
2024
Q1 		– Sell
-8
Closed – – 2578
2023
Q4 		$0 Buy
+8
New +$234 ﹤0.01% 2650
2023
Q3 		– Sell
-12
Closed – – 2231
2023
Q2 		$0 Buy
+12
New +$496 ﹤0.01% 2394

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Blue Trust Inc's PCRX Position: Q4 2024 in Review

Blue Trust Inc sold out of Pacira BioSciences (PCRX) in Q4 2024, closing a stake of 59 shares — an estimated $1.69K sold.

Blue Trust Inc first reported a position in PCRX in Q2 2023 and held it in 4 quarters. The position peaked at $1.69K in Q3 2024. 233 funds tracked by Wall St. Rank hold PCRX as of Q4 2024.

  • Blue Trust Inc reported no remaining Pacira BioSciences position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 59 Pacira BioSciences shares in Q4 2024, an estimated $1.69K.
  • Blue Trust Inc first reported a position in Pacira BioSciences in Q2 2023 and held it in 4 quarters.
  • Blue Trust Inc's Pacira BioSciences position peaked at $1.69K in Q3 2024.
  • 233 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.